| 1 |
Carey RM, Siragy HM. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation [J]. Endocr Rev, 2003, 24(3): 261-271.
|
| 2 |
Zhuo JL, Li XC. New insights and perspectives on intrarenal rennin-angiotensin system: focus on intracrine/intracellular angiotensin Ⅱ [J]. Peptides, 2011, 32(7): 1551-1565.
|
| 3 |
Kucharewicz I, Pawlak R, Matys T, et al. Angiotensin-(1-7): an active member of the renin-angiotensin system [J]. J Physiol Pharmacol, 2002, 53(4 Pt 1): 533-540.
|
| 4 |
Ferrario CM, Varagic J. The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function [J]. Am J Physiol Renal Physiol,2010, 298(6): F1297-F1305.
|
| 5 |
Dias-Peixoto MF, Ferreira AJ, Almeida PW, et al. The cardiac expression of Mas receptor is responsive to different physiological and pathological stimuli [J]. Peptides, 2012, 35(2): 196-201.
|
| 6 |
Gwathmey TM, Westwood BM, Pirro NT, et al. Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide [J]. Am J Physiol Renal Physiol, 2010, 299(5):F983-F990.
|
| 7 |
Kucharewicz I, Pawlak R, Matys T, et al. Angiotensin-(1-7): an active member of the renin-angiotensin system [J]. J Physiol Pharmacol, 2002, 53(4 Pt 1): 533-540.
|
| 8 |
Campbell DJ. Critical review of prorenin and (pro)renin receptor research [J]. Hypertension, 2008, 51(5): 1259-1264.
|
| 9 |
Hostetter TH, Ibrahim HN. Aldosterone in chronic kidney and cardiac disease [J]. J Am Soc Nephrol, 2003, 14(9): 2395-2401.
|
| 10 |
Ellis B, Li XC, Miguel-Qin E, et al. Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney [J]. Am J Physiol Regul Integr Comp Physiol, 2012,302(5): R494-R509.
|
| 11 |
Kobori H, Nangaku M, Navar LG, et al. The intrarenal reninangiotensin system: from physiology to the pathobiology of hypertension and kidney disease [J]. Pharmacol Rev, 2007, 59(3):251-287.
|
| 12 |
Li H, Weatherford ET, Davis DR, et al. Renal proximal tubule angiotensin AT1A receptors regulate blood pressure [J]. Am J Physiol Regul Integr Comp Physiol, 2011, 301(4): R1067-R1077.
|
| 13 |
Zhuo JL, Li XC. Novel roles of intracrine angiotensin Ⅱ and signalling mechanisms in kidney cells [J]. J Renin Angiotensin Aldosterone Syst, 2007, 8(1): 23-33.
|
| 14 |
Putnam K, Shoemaker R, Yiannikouris F,et al. The reninangiotensin system: a target of and contributor to dyslipidemias,altered glucose homeostasis, and hypertension of the metabolic syndrome [J]. Am J Physiol Heart Circ Physiol, 2012, 302(6):H1219-H1230.
|
| 15 |
Paulis L, Unger T. Novel therapeutic targets for hypertension [J].Nat Rev Cardiol, 2010, 7(8): 431-441.
|
| 16 |
Krum H, Gilbert RE. Novel therapies blocking the reninangiotensin-aldosterone system in the management of hypertension and related disorders [J]. J Hypertens, 2007, 25(1): 25-35.
|
| 17 |
Werner C, Pöss J, Böhm M. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy[J]. Drugs, 2010, 70(10): 1215-1230.
|
| 18 |
Li H, Weatherford ET, Davis DR, et al. Renal proximal tubule angiotensin AT1A receptors regulate blood pressure [J]. Am J Physiol Regul Integr Comp Physiol, 2011, 301(4): R1067-R1077.
|
| 19 |
Jauregui A, Mintz D, Mundel P, et al. Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria [J]. Curr Opin Nephrol Hypertens, 2009,18(6): 539-545.
|